CVI Investments, Inc. and Heights Capital Management, Inc. filed Amendment No. 3 to a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of common stock in 60 Degrees Pharmaceuticals, Inc., a pharmaceutical company headquartered in Washington, D.C.
Key Highlights
- Beneficial ownership: CVI Investments, Inc. and Heights Capital Management, Inc. each reported beneficial ownership of 197,911 shares of 60 Degrees Pharmaceuticals common stock.
- Percent of class: The 197,911 shares represent 5.3% of the outstanding common stock of 60 Degrees Pharmaceuticals, Inc.
- Warrant-based position: According to the filing, the shares reported consist entirely of shares issuable upon exercise of warrants, not shares held outright.
- Voting and dispositive power: Both reporting persons reported zero sole voting or dispositive power, with shared voting and shared dispositive power each at 197,911 shares.
- Investment manager relationship: Heights Capital Management, Inc. is identified as the investment manager to CVI Investments, Inc. and may exercise voting and dispositive power over the reported shares.
- Triggering event date: The date of the event requiring this filing was September 30, 2026.
- Shares outstanding reference: The filing cited 3,516,988 shares outstanding as of August 14, 2026, per the company's quarterly report filed on that date.
CVI Investments and Heights Capital Disclose Warrant-Backed Position in 60 Degrees Pharmaceuticals
According to the filing, CVI Investments, Inc., a Cayman Islands entity, and Heights Capital Management, Inc., a Delaware corporation based in San Francisco, California, jointly submitted Amendment No. 3 to a Schedule 13G covering shares of 60 Degrees Pharmaceuticals, Inc. common stock, par value $0.0001 per share (CUSIP: 83006G500). The filing was signed by Sarah Travis, identified as Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc., on November 12, 2026. 60 Degrees Pharmaceuticals is a pharmaceutical issuer with principal executive offices located at 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036.
The filing disclosed that the entire position of 197,911 shares is composed of shares issuable upon exercise of warrants. The warrants contain a beneficial ownership limitation provision: according to the filing, the warrants "are not exercisable to the extent that the total number of Shares then beneficially owned by a Reporting Person and its affiliates and any other persons whose beneficial ownership of Shares would be aggregated with such Reporting Person for purposes of Section 13(d) of the Exchange Act, would exceed 9.99%." Neither reporting person claimed sole voting or dispositive power over any shares; both shared voting and dispositive power are listed at 197,911 shares.
The filing noted that Heights Capital Management, Inc. serves as the investment manager to CVI Investments, Inc. and, as such, may be deemed the beneficial owner of all shares reported by CVI Investments. The filing also stated that "each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein." The filing certified that the securities were not acquired for the purpose of changing or influencing control of the issuer.
What Was Disclosed
CVI Investments, Inc. and Heights Capital Management, Inc. disclosed a combined beneficial ownership of 197,911 warrant-based shares in 60 Degrees Pharmaceuticals, Inc., representing 5.3% of the outstanding common stock, as of a triggering event dated September 30, 2026.




Please wait processing your request...